1,996
Views
0
CrossRef citations to date
0
Altmetric
HPV

The association of caregiver attitudes, information sources, and trust with HPV vaccine initiation among adolescents

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2300879 | Received 04 Sep 2023, Accepted 28 Dec 2023, Published online: 04 Jan 2024

References

  • Meites E, Gee J, Unger E, Markowitz L. Epidemiology and prevention of vaccine-preventable diseases: human papillomavirus. Washington (DC): Public Health Foundation; 2021.
  • Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660–9. doi:10.1097/OLQ.0000000000000193.
  • Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M. Human papillomavirus–associated cancers—United States, 2008–2012. Morb Mort Wkly Rep. 2016;65(26):661–6. doi:10.15585/mmwr.mm6526a1.
  • Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928–43. doi:10.1056/NEJMoa061760.
  • Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination – updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–8. doi:10.15585/mmwr.mm6549a5.
  • Saslow D, Andrews KS, Manassaram‐Baptiste D, Smith RA, Fontham ETH. Human papillomavirus vaccination 2020 guideline update: American cancer society guideline adaptation. Cancer J Clin. 2020;70(4):274–80. doi:10.3322/caac.21616.
  • O’Leary S, Nyquist TA-C. Why AAP recommends initiating HPV vaccination as early as age 9. AAP news. American Academy of Pediatrics; 2019.
  • Office of Disease Prevention and Health Promotion. Healthy People 2030. https://health.gov/healthypeople.
  • Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Williams CL, Fredua B, McNamara LA, Stokley S, Singleton JA. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2020. Morb Mort Wkly Rep. 2021;70(35):1183. doi:10.15585/mmwr.mm7035a1.
  • Peterson CE, Silva A, Holt HK, Balanean A, Goben AH, Dykens JA. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review. Cancer Cause Control. 2020;31(9):801–14. doi:10.1007/s10552-020-01323-y.
  • Franco M, Mazzucca S, Padek M, Brownson RC. Going beyond the individual: how state-level characteristics relate to HPV vaccine rates in the United States. BMC Public Health. 2019;19(1):1–9. doi:10.1186/s12889-019-6566-y.
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.
  • Mansfield LN, Vance A, Nikpour JA, Gonzalez‐Guarda RM. A systematic review of human papillomavirus vaccination among US adolescents. Res Nurs Health. 2021;44(3):473–89. doi:10.1002/nur.22135.
  • Rodriguez SA, Mullen PD, Lopez DM, Savas LS, Fernández ME. Factors associated with adolescent HPV vaccination in the US: a systematic review of reviews and multilevel framework to inform intervention development. Prev Med. 2020;131:105968. doi:10.1016/j.ypmed.2019.105968.
  • Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45(5):528–31. doi:10.1016/j.jadohealth.2009.02.006.
  • Shato T, Humble S, Anandarajah A, Barnette A, Brandt HM, Garbutt J, Klesges L, Thompson VS, Silver MI. Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states. Vaccine. 2023;41(25):3772–3781. doi:10.1016/j.vaccine.2023.04.082.
  • Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7(5):e1000270. doi:10.1371/journal.pmed.1000270.
  • Staras SA, Vadaparampil ST, Patel RP, Shenkman EA. Parent perceptions important for HPV vaccine initiation among low income adolescent girls. Vaccine. 2014;32(46):6163–9. doi:10.1016/j.vaccine.2014.08.054.
  • Fu LY, Zimet GD, Latkin CA, Joseph JG. Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents. Vaccine. 2017;35(5):802–7. doi:10.1016/j.vaccine.2016.12.045.
  • Cox JE, Bogart LM, Elliott MN, Starmer AJ, Meleedy-Rey P, Goggin K, Banerjee T, Samuels RC, Hahn PD, Epee-Bounya A, et al. Improving HPV vaccination rates in a racially and ethnically diverse pediatric population. Pediatrics. 2022:150(4). doi:10.1542/peds.2021-054186
  • Rosen BL, Shew ML, Zimet GD, Ding L, Mullins TLK, Kahn JA. Human papillomavirus vaccine sources of information and adolescents’ knowledge and perceptions. Glob Pediatr Health. 2017;4:2333794X17743405. doi:10.1177/2333794X17743405.
  • McRee AL, Reiter PL, Brewer NT. Parents’ internet use for information about HPV vaccine. Vaccine. 2012;30(25):3757–62. doi:10.1016/j.vaccine.2011.11.113.
  • Thompson EL, Preston SM, Francis JKR, Rodriguez SA, Pruitt SL, Blackwell J-M, Tiro JA. Social media perceptions and internet verification skills associated with human papillomavirus vaccine decision-making among parents of children and adolescents: cross-sectional survey. JMIR Pediatr Parent. 2022;5(3):e38297. doi:10.2196/38297.
  • Paskett ED, Krok-Schoen JL, Pennell ML, Tatum CM, Reiter PL, Peng J, Bernardo BM, Weier RC, Richardson MS, Katz ML. Results of a multilevel intervention trial to increase human papillomavirus (HPV) vaccine uptake among adolescent girls. Cancer Epidemiol Biomarkers Prev. 2016;25(4):593–602. doi:10.1158/1055-9965.EPI-15-1243.
  • Calo WA, Lennon RP, Ruffin IV MT, Keller C, Spanos K, D’Souza G, Kraschnewski JL. Support for HPV vaccine school-entry requirements in the United States: the role of exemption policies. Vaccine. 2022;40(51):7426–32. doi:10.1016/j.vaccine.2022.08.019.
  • MenACWY vaccine requirements for secondary school. 2023 Aug 17 [accessed 2023 Dec 12]. https://www.immunize.org/official-guidance/state-policies/vaccine-requirements/menacwy-secondary/.
  • Brewer NT, Gottlieb SL, Reiter PL, McRee A-L, Liddon N, Markowitz L, Smith JS. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197–204. doi:10.1097/OLQ.0b013e3181f12dbf.
  • Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, Gottlieb SL. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011;29(12):2235–41. doi:10.1016/j.vaccine.2011.01.052.
  • Gottlieb SL, Brewer NT, Sternberg MR, Smith JS, Ziarnowski K, Liddon N, Markowitz LE. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–7. doi:10.1016/j.jadohealth.2009.03.029.
  • Dempsey AF, O’Leary ST. Human papillomavirus vaccination: narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Acad Pediatr. 2018;18(2S):S23–S7. doi:10.1016/j.acap.2017.09.001.
  • Broniatowski DA, Dredze M, Ayers JW. “First do no harm”: effective communication about COVID-19 vaccines. Am J Public Health. 2021;111(6):1055–7. doi:10.2105/AJPH.2021.306288.
  • Kelly BJ, Leader AE, Mittermaier DJ, Hornik RC, Cappella JN. The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? Patient Educ Couns. 2009;77(2):308–13. doi:10.1016/j.pec.2009.03.018.
  • Quintero Johnson J, Sionean C, Scott AM. Exploring the presentation of news information about the HPV vaccine: a content analysis of a representative sample of U.S. newspaper articles. Health Commun. 2011;26(6):491–501. doi:10.1080/10410236.2011.556080.
  • Habel MA, Liddon N, Stryker JE. The HPV vaccine: a content analysis of online news stories. J Womens Health (Larchmt). 2009;18(3):401–7. doi:10.1089/jwh.2008.0920.
  • Ekram S, Debiec KE, Pumper MA, Moreno MA. Content and commentary: HPV vaccine and YouTube. J Pediatr Adolesc Gynecol. 2019;32(2):153–7. doi:10.1016/j.jpag.2018.11.001.
  • Chhabra R, Chisolm DJ, Bayldon B, Quadri M, Sharif I, Velazquez JJ, Encalada K, Rivera A, Harris M, Levites-Agababa E, et al. Evaluation of pediatric human papillomavirus vaccination provider counseling written materials: a health literacy perspective. Acad Pediatr. 2018;18(2):S28–S36. doi:10.1016/j.acap.2017.08.004.
  • Abdelmutti N, Hoffman-Goetz L. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles. Women Health. 2009;49(5):422–40. doi:10.1080/03630240903238776.
  • Calo WA, Gilkey MB, Malo TL, Robichaud M, Brewer NT. A content analysis of HPV vaccination messages available online. Vaccine. 2018;36(49):7525–9. doi:10.1016/j.vaccine.2018.10.053.
  • MacLean SA, Basch CH, Ethan D, Garcia P. Readability of online information about HPV immunization. Hum Vaccin Immunother. 2019;15(7–8):1505–7. doi:10.1080/21645515.2018.1502518.
  • Helitzer D, Hollis C, Cotner J, Oestreicher N. Health literacy demands of written health information materials: an assessment of cervical cancer prevention materials. Cancer Control. 2009;16(1):70–8. doi:10.1177/107327480901600111.
  • Coughlin SS, Vernon M, Hatzigeorgiou C, George V. Health literacy, social determinants of health, and disease prevention and control. J Environ Health Sci. 2020;6(1):3061.
  • Weis BD. Health literacy: a manual for clinicians. Chicago (IL): American Medical Association Foundation and American Medical Association; 2003.
  • Daraz L, Morrow AS, Ponce OJ, Farah W, Katabi A, Majzoub A, Seisa MO, Benkhadra R, Alsawas M, Larry P, et al. Readability of online health information: a meta-narrative systematic review. Am J Med Qual. 2018;33(5):487–92. doi:10.1177/1062860617751639.